Compare CIVB & OFIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | CIVB | OFIX |
|---|---|---|
| Founded | 1884 | 1987 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Medical/Dental Instruments |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 476.9M | 473.3M |
| IPO Year | 2012 | 1998 |
| Metric | CIVB | OFIX |
|---|---|---|
| Price | $23.59 | $12.47 |
| Analyst Decision | Buy | Buy |
| Analyst Count | 6 | 5 |
| Target Price | ★ $25.83 | $17.25 |
| AVG Volume (30 Days) | 74.8K | ★ 225.6K |
| Earning Date | 04-22-2026 | 05-05-2026 |
| Dividend Yield | ★ 3.01% | N/A |
| EPS Growth | ★ 31.34 | 29.39 |
| EPS | ★ 2.64 | N/A |
| Revenue | $19,023,000.00 | ★ $822,312,000.00 |
| Revenue This Year | $14.98 | $6.10 |
| Revenue Next Year | $6.60 | $6.24 |
| P/E Ratio | $9.08 | ★ N/A |
| Revenue Growth | N/A | ★ 2.85 |
| 52 Week Low | $18.95 | $10.25 |
| 52 Week High | $25.59 | $16.99 |
| Indicator | CIVB | OFIX |
|---|---|---|
| Relative Strength Index (RSI) | 55.60 | 54.55 |
| Support Level | $23.35 | $12.33 |
| Resistance Level | $24.76 | $16.38 |
| Average True Range (ATR) | 0.62 | 0.41 |
| MACD | 0.11 | 0.17 |
| Stochastic Oscillator | 69.60 | 73.66 |
Civista Bancshares Inc is a financial holding company. Operating through its subsidiary, it engages in the business of community banking. Its business activity involves collecting customer deposits, making loans, purchasing securities, and offering trust services to its clients. The company's loan portfolio includes commercial and agricultural, commercial real estate-owner occupied, commercial real estate non-owner occupied, residential real estate, real estate construction, and consumer loans. The majority of its revenues are derived from the interest and fees gained on loans.
Orthofix Medical Inc. is a medical device company delivering orthopedic and spine solutions to healthcare providers. The company has two reportable segments: Global Spine and Global Limb Reconstruction. The Global Spine segment offers bone growth therapies, spinal implants, biologics, and enabling technologies used in spinal procedures. The Global Limb Reconstruction segment provides products and solutions for limb deformity correction, limb lengthening, fracture management, and limb preservation, supported by digital technologies. It generates the majority of its revenue from the Global Spine segment.